Runx3 inhibits endothelial progenitor cell differentiation and function via suppression of HIF-1α activity.

Endothelial progenitor cells (EPCs) are bone marrow (BM)‑derived progenitor cells that can differentiate into mature endothelial cells, contributing to vasculogenesis in the blood vessel formation process. Runt‑related transcription factor 3 (RUNX3) belongs to the Runt domain family and is required for the differentiation of specific immune cells and neurons. The tumor suppressive role of RUNX3, via the induction of apoptosis and cell cycle arrest in a variety of cancers, and its deletion or frequent silencing by epigenetic mechanisms have been studied extensively; however, its role in the differentiation of EPCs is yet to be investigated. Therefore, in the present study, adult BM‑derived hematopoietic stem cells (HSCs) were isolated from Runx3 heterozygous (Rx3+/‑) or wild‑type (WT) mice. The differentiation of EPCs from the BM‑derived HSCs of Rx3+/‑ mice was found to be significantly increased compared with those of the WT mice, as determined by the number of small or large colony‑forming units. The migration and tube formation abilities of Rx3+/‑ EPCs were also observed to be significantly increased compared with those of WT EPCs. Furthermore, the number of circulating EPCs, defined as CD34+/vascular endothelial growth factor receptor 2 (VEGFR2)+ cells, was also significantly increased in Rx3+/‑ mice. Hypoxia‑inducible factor (HIF)‑1α was upregulated in Rx3+/‑ EPCs compared with WT EPCs, even under normoxic conditions. Furthermore, in a hindlimb ischemic mouse models, the recovery of blood flow was observed to be highly stimulated in Rx3+/‑ mice compared with WT mice. Also, in a Lewis lung carcinoma cell allograft model, the tumor size in Rx3+/‑ mice was significantly larger than that in WT mice, and the EPC cell population (CD34+/VEGFR2+ cells) recruited to the tumor was greater in the Rx3+/‑ mice compared with the WT mice. In conclusion, the present study revealed that Runx3 inhibits vasculogenesis via the inhibition of EPC differentiation and functions via the suppression of HIF‑1α activity.

[1]  H. Kestler,et al.  RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features , 2016, Leukemia.

[2]  V. Rosti,et al.  Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy , 2015, Tumor Biology.

[3]  J. M. Ryu,et al.  Hypoxia accelerates vascular repair of endothelial colony-forming cells on ischemic injury via STAT3-BCL3 axis , 2015, Stem Cell Research & Therapy.

[4]  Y. M. Lee,et al.  Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion , 2015, Oncotarget.

[5]  A. Roccaro,et al.  Role of endothelial progenitor cells in cancer progression. , 2014, Biochimica et biophysica acta.

[6]  G. Oh,et al.  Hypoxia-Induced Endothelial Progenitor Cell Function Is Blunted in Angiotensinogen Knockout Mice , 2014, Molecules and cells.

[7]  S. Bae,et al.  RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells , 2014, Oncogene.

[8]  Min Young Lee,et al.  Inhibitory effect of glyceollins on vasculogenesis through suppression of endothelial progenitor cell function. , 2013, Molecular nutrition & food research.

[9]  M. Konopleva,et al.  Targeting hypoxia in the leukemia microenvironment. , 2013, International journal of hematologic oncology.

[10]  Yoshiaki Ito,et al.  RUNX family: Regulation and diversification of roles through interacting proteins , 2013, International journal of cancer.

[11]  C. Heeschen,et al.  Vascular Incorporation of Endothelial Colony-Forming Cells Is Essential for Functional Recovery of Murine Ischemic Tissue Following Cell Therapy , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[12]  H. Masuda,et al.  R EGENERATIVE M EDICINE Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine , 2022 .

[13]  Y. M. Lee,et al.  Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. , 2011, Journal of molecular and cellular cardiology.

[14]  H. Masuda,et al.  Methodological Development of a Clonogenic Assay to Determine Endothelial Progenitor Cell Potential , 2011, Circulation research.

[15]  W. Kamps,et al.  Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. , 2011, Cancer research.

[16]  Huanbai Xu,et al.  Clinicopathologic Significance of HIF-1α, CXCR4, and VEGF Expression in Colon Cancer , 2010, Clinical & developmental immunology.

[17]  Mark Sweeney,et al.  Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities , 2010, BMC Medical Genomics.

[18]  Yoshiaki Ito,et al.  RUNX3 is multifunctional in carcinogenesis of multiple solid tumors , 2010, Oncogene.

[19]  L. Iuliano,et al.  Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation , 2009 .

[20]  S. Stifani,et al.  'Runxs and regulations' of sensory and motor neuron subtype differentiation: implications for hematopoietic development. , 2009, Blood cells, molecules & diseases.

[21]  Y. M. Lee,et al.  Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells , 2009, Oncogene.

[22]  A. M. Leone,et al.  From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. , 2008, European heart journal.

[23]  H. Masuda,et al.  Specific Jagged-1 Signal From Bone Marrow Microenvironment Is Required for Endothelial Progenitor Cell Development for Neovascularization , 2008, Circulation.

[24]  S. Warren,et al.  The Effects of Flap Ischemia on Normal and Diabetic Progenitor Cell Function , 2008, Plastic and reconstructive surgery.

[25]  Ju-Young Kim,et al.  Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies , 2007, Circulation.

[26]  T. Dai,et al.  Migration of Endothelial Progenitor Cells Mediated by Stromal Cell-Derived Factor-1α/CXCR4 via PI3K/Akt/eNOS Signal Transduction Pathway , 2007, Journal of cardiovascular pharmacology.

[27]  D. Scheinberg,et al.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. , 2007, Genes & development.

[28]  Hua-mei Tang,et al.  RUNX3 Inhibits the Expression of Vascular Endothelial Growth Factor and Reduces the Angiogenesis, Growth, and Metastasis of Human Gastric Cancer , 2006, Clinical Cancer Research.

[29]  Y. Groner,et al.  Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Hannah J. Whiteman,et al.  Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells , 2005, Oncogene.

[31]  Seiji Fukuda,et al.  Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1. , 2005, Blood.

[32]  H. Masuda,et al.  Endothelial progenitor cells: past, state of the art, and future , 2004, Journal of cellular and molecular medicine.

[33]  T. Asahara,et al.  Endothelial progenitor cells for postnatal vasculogenesis. , 2004, American journal of physiology. Cell physiology.

[34]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[35]  Yoshiaki Ito.  Oncogenic potential of the RUNX gene family: ‘Overview’ , 2004, Oncogene.

[36]  Takeshi Imamura,et al.  Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins , 2004, Oncogene.

[37]  S. Fujimoto,et al.  [Vasculogenesis and angiogenesis]. , 2003, Journal of UOEH.

[38]  M. Petter,et al.  Morpholino Antisense Oligonucleotide-Mediated Gene Knockdown During Thymocyte Development Reveals Role for Runx3 Transcription Factor in CD4 Silencing During Development of CD4−/CD8+ Thymocytes 1 , 2003, The Journal of Immunology.

[39]  L. Claesson‐Welsh,et al.  VEGF receptor signal transduction. , 2003, Science's STKE : signal transduction knowledge environment.

[40]  J. Isner,et al.  Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.

[41]  M. Ratajczak,et al.  CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion , 2003, Journal of Molecular Histology.

[42]  D. Littman,et al.  Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development , 2002, Cell.

[43]  C. Westbrook,et al.  Novel transcription factors in human CD34 antigen-positive hematopoietic cells. , 2002, Blood.

[44]  Kathryn E. Crosier,et al.  Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. , 2002, Development.

[45]  S. Itohara,et al.  Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer , 2002, Cell.

[46]  T. Noda,et al.  A Role for Hematopoietic Stem Cells in Promoting Angiogenesis , 2000, Cell.

[47]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Hittelman,et al.  Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor α-Dependent Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[49]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[50]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[51]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[52]  Shinichiro Kumagaya,et al.  Fluid shear stress induces arterial differentiation of endothelial progenitor cells. , 2009, Journal of applied physiology.

[53]  T. Asahara,et al.  [Effects of statins on angiogenesis and vasculogenesis]. , 2002, Revista espanola de cardiologia.